Morbidity and mortality of ESCC present an increasing trend year by year as the 5-year survival rate is as low as 20% [ 3 , 4 ].
← all excerpts
Whole-transcriptome sequencing reveals hypoxic esophageal squamous cell carcinoma-derived migrasomes driving cancer-associated fibroblast activation.
1
—
—